INS and exocrine pancreatic insufficiency: For example, prior to the introduction of biotechnology-produced insulin, pig-derived insulin was the primary treatment for type I diabetes, and digestive enzymes harvested from porcine pancreases are used to treat human pancreatic insufficiency.